TASIn ForceAct
Poisons Act 1971
38BSecretary to establish and maintain monitored medicines database
Start here
Get a plain-English read of 38B
Turn the raw legal text into a practical explanation grounded in Poisons Act 1971.
### 38B Secretary to establish and maintain monitored medicines database
> [*\[Section 38B of Part III Inserted by No. 21 of 2021, s. 7, Applied:17 Dec 2021\]*](/view/html/inforce/2021-12-17/act-2021-021#GS7@EN)
>
> > (1) The Secretary is to establish and maintain an electronic database (the ***monitored medicines database***) to monitor and record –
> >
> > > > (a) information relating to the issuing of prescriptions for monitored medicines; and
> > >
> > > > (b) information relating to the dispensing of monitored medicines on and in accordance with a prescription; and
> > >
> > > > (c) information relating to the sale and supply of monitored medicines, otherwise than on and in accordance with a prescription, by a person who is authorised by or under this Act to sell or supply monitored medicines; and
> > >
> > > > (d) information obtained for the purposes of, or in connection with, the administration or enforcement of this Act; and
> > >
> > > > (e) any other prescribed information.
>
> > (2) The purposes of the monitored medicines database are –
> >
> > > > (a) to promote safe and effective practices for the issuing of prescriptions for monitored medicines; and
> > >
> > > > (b) to promote safe and effective practices for the dispensing of monitored medicines on and in accordance with a prescription; and
> > >
> > > > (c) to promote safe and effective practices for the sale and supply of monitored medicines, otherwise than on and in accordance with a prescription, by a person who is authorised by or under this Act to sell and supply monitored medicines; and
> > >
> > > > (d) to minimise the harm associated with monitored medicines and other high-risk substances; and
> > >
> > > > (e) to promote and protect public health and safety associated with the use of monitored medicines and other high-risk substances; and
> > >
> > > > (f) to facilitate the evaluation of, and research into, monitored medicines; and
> > >
> > > > (g) to facilitate the administration and enforcement of this Act; and
> > >
> > > > (h) any other prescribed purpose.